@article{5b72a725506848e3bca209cfff7f02b0,
title = "Treatment of immune thrombocytopenia with eltrombopag in patients who had and who had not received prior rituximab: post-hoc analysis of the EXTEND study",
author = "Oliver Meyer and Wong, \{Raymond S.M.\} and Abderrahim Khelif and Miona Stankovic and Joan Maier and Saleh, \{Mansoor N.\} and Bussel, \{James B.\}",
note = "Funding Information: This study was sponsored by Novartis. The authors thank Azura Charles, MSc, and Shilu Amin, PhD, of Chameleon Communications, London, UK, for providing medical writing support, which was funded by Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA, in accordance with Good Publication Practice (GPP3) guidelines ( http://www.ismpp.org/gpp3 ). ",
year = "2022",
month = jan,
doi = "10.1111/bjh.17800",
language = "English (US)",
volume = "196",
pages = "448--452",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "John Wiley and Sons Inc.",
number = "2",
}